Extended Experience with Recombinant a-2b Interferon with OR Without Hepatic Artery Embolization in the Treatment OF Midgut Carcinoid Tumours A preliminary report
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 30 (4) , 523-527
- https://doi.org/10.3109/02841869109092412
Abstract
(1991). Extended Experience with Recombinant a-2b Interferon with OR Without Hepatic Artery Embolization in the Treatment OF Midgut Carcinoid Tumours A preliminary report. Acta Oncologica: Vol. 30, No. 4, pp. 523-527. doi: 10.3109/02841869109092412Keywords
This publication has 20 references indexed in Scilit:
- Treatment of Malignant Metastatic Midgut Carcinoid Tumours with Recombinant Human o2b Interferon with or without Prior Hepatic Artery EmbolizationScandinavian Journal of Gastroenterology, 1989
- Approach to Hepatic Involvement by Endocrine Tumors of the Gastrointestinal TractSeminars in Liver Disease, 1988
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- Control of carcinoid syndrome with hepatic artery embolization.Radiology, 1985
- Embolization of the liver in the management of metastatic carcinoid tumorsJournal of Surgical Oncology, 1984
- Treatment of the carcinoid tumor and the malignant carcinoid syndrome.Journal of Clinical Oncology, 1983
- Role of hepatic arterial embolisation in the carcinoid syndrome.BMJ, 1983
- Effects of Leukocyte Interferon on Clinical Symptoms and Hormone Levels in Patients with Mid-Gut Carcinoid Tumors and Carcinoid SyndromeNew England Journal of Medicine, 1983
- The Carcinoid FlushNew England Journal of Medicine, 1978
- Unusual cyanosis in a boy with congenital pulmonary stenosis and tricuspid insufficiency. Fatal outcome after angiocardiographyAmerican Heart Journal, 1952